Clinical suspicion, diagnosis and management of cardiac amyloidosis: update and executive summary

被引:0
|
作者
Yun, S. [1 ,2 ,3 ,4 ]
Casado, J. [5 ,6 ]
Perez-Silvestre, J. [7 ]
Salamanca, P. [8 ,9 ]
Llacer, P. [10 ,11 ]
Quiros, R. [12 ,13 ]
Ruiz-Hueso, R. [8 ]
Mendez, M. [14 ]
Manzano, L. [10 ,11 ]
Formiga, F. [3 ,15 ]
机构
[1] Inst Invest Biomed Bellvitge IDIBELL, Bioheart Cardiovasc Dis Res Grp, Barcelona, Spain
[2] Hosp Univ Bellvitge, Serv Cardiol & Med Interna, Programa Atenc Insuficiencia Cardiaca Comunitaria, Barcelona, Spain
[3] Hosp Univ Bellvitge, Serv Med Interna, Barcelona, Spain
[4] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Cardiovasc CIBE, Madrid, Spain
[5] Hosp Univ Getafe, Serv Med Interna, Madrid, Spain
[6] Univ Europea Madrid, Madrid, Spain
[7] Consorcio Hosp Gen Univ Valencia, Serv Med Interna, UMIPIC, Valencia, Spain
[8] Hosp Univ Virgen Macarena, Serv Med Interna, Seville, Spain
[9] Univ Seville, Dept Med, Seville, Spain
[10] Hosp Univ Ramon y Cajal, IRYCIS, Serv Med Interna, Madrid, Spain
[11] Univ Alcala, Fac Med & Ciencias Salud, Dept Med & Especialidades Med, Madrid, Spain
[12] Hosp Costa Sol, Serv Med Interna, Malaga, Spain
[13] Red Invest Cronicidad Atenc Primaria & Prevenc & P, Madrid, Spain
[14] Univ Complutense, Hosp Clin San Carlos, Serv Med Interna, Fac Med,Inst Invest Sanitaria Hosp Clin San Carlos, Madrid, Spain
[15] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain
来源
REVISTA CLINICA ESPANOLA | 2024年 / 224卷 / 05期
关键词
Cardiac amyloidosis; Heart failure; Red flags; Clinical suspicion; Early diagnosis; CARPAL-TUNNEL-SYNDROME; HEART-FAILURE; AORTIC-STENOSIS; ATTR AMYLOIDOSIS; COMMON; PATHOPHYSIOLOGY;
D O I
10.1016/j.rce.2024.03.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, the interest in cardiac amyloidosis has grown exponentially. However, there is a need to improve our understanding of amyloidosis in order to optimise early detection systems. Therefore, it is crucial to incorporate solutions to improve the suspicion, diagnosis and follow-up of cardiac amyloidosis. In this sense, we designed a tool following the different phases to reach the diagnosis of cardiac amyloidosis, as well as an optimal follow-up: a) clinical suspicion, where the importance of the "red flags" to suspect it and activate the diagnostic process is highlighted; 2) diagnosis, where the diagnostic algorithm is mainly outlined; and 3) follow-up of confirmed patients. This is a practical resource that will be of great use to all professionals caring for patients with suspected or confirmed cardiac amyloidosis, to improve its early detection, as well as to optimise its accurate diagnosis and optimal follow-up. (c) 2024 Elsevier Espa & ntilde;a, S.L.U. and Sociedad Espa & ntilde;ola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:288 / 299
页数:12
相关论文
共 50 条
  • [1] Cardiac amyloidosis: from clinical suspicion to morphological diagnosis
    Flodrova, Pavla
    Flodr, Patrik
    Pika, Tomas
    Vymetal, Jiri
    Holub, Dusan
    Dzubak, Petr
    Hajduch, Marian
    Scudla, Vlastimil
    PATHOLOGY, 2018, 50 (03) : 261 - 268
  • [2] Clinical suspicion of cardiac amyloidosis
    Pannu, A. K.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 116 (05) : 400 - 400
  • [3] Cardiac amyloidosis : An update on diagnosis and treatment
    Donnelly, Joseph P.
    Hanna, Mazen
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 : 12 - 26
  • [4] Early diagnosis and management of cardiac amyloidosis: A clinical perspective
    Bellofatto, Ilaria Anna
    Schindler, Thomas H.
    Portincasa, Piero
    Carbone, Federico
    Canepa, Marco
    Liberale, Luca
    Montecucco, Fabrizio
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (06)
  • [5] Cardiac amyloidosis: A diagnosis made from an ophthalmological finding and suspicion
    Allendes-Urquiza, German
    Alvarez, Yolanda Castro
    Montejano-Milner, Rafael
    Teus, Miguel A.
    Arruabarrena, Carolina
    REVISTA ESPANOLA DE PATOLOGIA, 2025, 58 (02):
  • [6] Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
    Maurer, Mathew S.
    Bokhari, Sabahat
    Damy, Thibaud
    Dorbala, Sharmila
    Drachman, Brian M.
    Fontana, Marianna
    Grogan, Martha
    Kristen, Arnt V.
    Lousada, Isabelle
    Nativi-Nicolau, Jose
    Cristina Quarta, Candida
    Rapezzi, Claudio
    Ruberg, Frederick L.
    Witteles, Ronald
    Merlini, Giampaolo
    CIRCULATION-HEART FAILURE, 2019, 12 (09)
  • [7] Guidelines on management (diagnosis and treatment) of Syncope. Update 2004. Executive summary
    Brignole, M
    Alboni, P
    Benditt, DG
    Bergfeldt, L
    Blanc, JJ
    Thomsen, PEB
    van Dijk, JG
    Fitzpatrick, A
    Hohnloser, S
    Janousek, J
    Kapoor, W
    Kenny, RA
    Kulakowski, P
    Masotti, G
    Moya, A
    Raviele, A
    Sutton, R
    Theodorakis, G
    Ungar, A
    Wieling, W
    REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (02): : 175 - 193
  • [8] Diagnosis and management of cardiac amyloidosis
    不详
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (02):
  • [9] Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
    Siddiqi, Omar K.
    Ruberg, Frederick L.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2018, 28 (01) : 10 - 21
  • [10] Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options
    Alkhawam, Hassan
    Patel, Darshan
    Nguyen, James
    Easaw, Saumya Mariam
    Al-Sadawi, Mohammed
    Syed, Umer
    Zaiem, Feras
    Homsi, Maher
    Vittorio, Timothy J.
    ACTA CARDIOLOGICA, 2017, 72 (04) : 380 - 389